Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
Toronto General Hospital Research Institute (TGHRI) is happy to announce that this year’s Research Day will be held on Wednesday October 17th, 2018 at the Toronto Reference Library.
This year’s keynote speakers will be:
Dr. Reinhart Reithmeier, Professor and Chair, Department of Biochemistry, University of Toronto will be presenting “The 10,000 PhDs Project: Implications for Graduate Education”
Dr. Florent Ginhoux , Principal Investigator to Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) will be presenting “Macrophage and Dendritic Cell Biology”